Back to Agenda
Session 2: Pharmacovigilance Updates & Collaboration Efforts From Around the Globe
Session Chair(s)
Shahinaz Badr
Pharmacovigilance Consultant and PVQA Auditor - EMEA
Pharma Quality Europe, United Arab Emirates
Willemijn van der Spuij, MSc
Executive Director, WorldWide Patient Safety International, Europe
Switzerland
This truly global session aims to provide insights into the latest developments in Pharmacovigilance. The session will take you on a journey around the world, starting with an exploration of PV requirements and experiences in Kazakhstan. We will then move on to the PV environment and collaborative efforts in Brazil. Next, we will focus on important PV developments in the Asia Pacific region. The session will highlight key aspects that impact the role of the QPPV. You will have the opportunity to engage directly with experts from the industry and regulatory agencies during the panel discussion.
Speaker(s)
Kazakhstan - Industry Experience of the Regulatory Framework and Interpretation to Inspection Experiences
Willemijn van der Spuij, MSc
Switzerland
Executive Director, WorldWide Patient Safety International, Europe
Asia PAC Region – Increasing Role of NQPs Over Time
Representative Invited
Switzerland
Local QPPV Role in Egypt
Maha Mohamed Ahmed
Egyptian Drug Authority (EDA), Egypt
Acting Director of the general department of pharmacovigilance
LatAmScience LLC
United States
Diana Gonzalez
Colombia
Have an account?